STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[144] CeriBell, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

CeriBell, Inc. (CBLL) submitted a Form 144 reporting a proposed sale of 866 common shares, with an aggregate market value of $10,142.93. The shares are part of a restricted stock vesting acquired on 08/20/2025 and paid as compensation. The sale is planned through Fidelity Brokerage Services LLC on 08/27/2025 and the securities trade on NASDAQ. The filer certifies no undisclosed material adverse information about the issuer. There were no sales by the filer in the prior three months reported.

Positive
  • Transparent disclosure of the proposed sale through Form 144 and identification of the broker and exchange
  • Securities originated from restricted stock vesting, indicating the sale is a routine conversion of compensation into liquid shares
  • No reported sales in prior three months, suggesting this is not part of a pattern of frequent insider dispositions
Negative
  • None.

Insights

TL;DR: Small insider sale of vested compensation shares; immaterial to capitalization but worth monitoring for insider behavior.

The filing shows a proposed sale of 866 shares valued at $10,142.93, representing a negligible portion of the company's outstanding common stock (36,663,968 shares). Since the shares were acquired via restricted stock vesting and paid as compensation, this is a routine liquidity event for an insider or employee rather than a market-driven divestiture. The transaction is unlikely to affect company valuation or market supply materially, but it does provide limited insight into insider selling behavior.

TL;DR: Routine compliance filing following vesting; demonstrates adherence to disclosure rules and Rule 144 requirements.

The Form 144 documents compliance with securities law for the proposed sale via an established broker and includes the required representations about material nonpublic information. The timing—acquisition on 08/20/2025 and planned sale on 08/27/2025—aligns with a typical post-vesting disposition. From a governance perspective, the filing is standard and reflects procedural transparency rather than a governance red flag.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does CeriBell's (CBLL) Form 144 report?

The filing reports a proposed sale of 866 common shares valued at $10,142.93, to be sold on 08/27/2025 via Fidelity Brokerage Services on NASDAQ.

How were the 866 shares acquired according to the filing?

The shares were acquired on 08/20/2025 through restricted stock vesting and the consideration is listed as compensation.

Does the filing indicate any undisclosed material information about CeriBell?

The signer represents that they do not know any material adverse information

Were there any securities sold by the filer in the prior three months?

The filing states Nothing to Report for securities sold during the past three months.

Who is the broker handling the proposed sale in the Form 144?

The broker listed is Fidelity Brokerage Services LLC located at the address provided in the filing.
CeriBell, Inc.

NASDAQ:CBLL

CBLL Rankings

CBLL Latest News

CBLL Latest SEC Filings

CBLL Stock Data

489.66M
29.22M
10.43%
84.44%
3.61%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
SUNNYVALE